DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the CAMLIN FINE SCIENCES LTD (CAMLINFINE) share price today?

CAMLIN FINE SCIENCES LTD (CAMLINFINE) is trading at ₹122.69 on the NSE, down 1.79% on the day. Source: DocStoX.

What is the PE ratio of CAMLIN FINE SCIENCES LTD?

CAMLIN FINE SCIENCES LTD has a price-to-earnings (PE) ratio of 85.2 in the Chemicals sector.

What is the market capitalisation of CAMLIN FINE SCIENCES LTD?

CAMLIN FINE SCIENCES LTD has a market capitalisation of approximately ₹2,354 crore.

CAMLIN FINE SCIENCES LTD

CAMLINFINE·NSE·Chemicals

₹122.69▼ -2.24 (-1.79%)

Chemicals · Specialty Chemicals

A steady, established business

Day₹121.25

₹124.56

52W₹96

₹29913%

Open

₹124.55

High

₹124.56

Low

₹121.25

Prev Close

₹124.93

Volume

4.63L

VWAP

₹122.46

Snapshot

Key fundamentals

Market Cap

₹2,354 Cr

P/E Ratio

85.20Expensive

P/B Ratio

2.51

EPS

₹1.44

Book Value

₹54.20

ROE

1.26%Weak

ROCE

4.00%Weak

Dividend Yield

0.00%

Debt / Equity

0.69Moderate

Face Value

₹1.00

52W High

₹299.45

52W Low

₹96.21

Sector

Chemicals

Industry

Specialty Chemicals

Avoid

None moatHigh uncertainty

Fair value estimate

₹45

▼ 63.5%downside

Trading at ₹123 — 64% above our estimate

BearFair valueBull

₹38₹45₹51

/100

Business quality — Watch the fundamentals

Growth 2Profitability 0Efficiency 0Valuation 33

Plain English

Our view

A steady, established business
Weak returns on equity (1%)

Risks

Weak returns on equity (1%)
Expensive — trades at 85× earnings
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

1% ROE fading to 14% over ~3 yrs, on ₹54 book

₹46

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹42

Analyst target

No analyst coverage

—

Blended fair value₹45

What the numbers say

Investment thesis

Bull case

No standout positives from the current metrics.

Bear case

Weak returns on equity (1%)
Expensive — trades at 85× earnings
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

85.2Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

1.3%Weak

Above 15% is considered healthy for Indian equities

ROCE

4.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.69Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹2,354 Cr

P/B

2.51

EPS

₹1.44

Div Yield

—

What changed

Recent changes

Domestic institutions-2.3% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 85.2×

Growth

Slow

+1% rev CAGR

Profitability

Modest

1.3% ROE

Financial health

Comfortable

D/E 0.69

Momentum

N/A

No technicals

Today

Trading activity

Delivery %45.5%

Turnover₹567.46L Cr

Trades4,829

VWAP₹122.46

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+0.8%

+7.7%

10Y

+13.4%

Profit

-15.7%

-18.1%

10Y

-4.0%

EPS

-21.4%

-16.6%

10Y

-8.0%

Profile

Pros

Company's working capital requirements have reduced from 36.4 days to 23.0 days

Watch-outs

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of 7.74% over past five years.
Company has a low return on equity of -7.88% over last 3 years.
Earnings include an other income of Rs.60.1 Cr.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions reduced 2.28 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

48%

Promoter

Promoters

48.0%0.00

Public

45.6%+2.32

FII / FPI

0.9%-0.03

DII

5.4%-2.28

Quarterly trend

Ownership over time

Q1 FY27

Promoter48.03%

FII0.91%

DII5.42%

Public45.63%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.